'Transformational' new drug could stop breast cancer tumours before they grow, trial finds
A new drug could stop some breast cancer tumours from using hormones to grow, a trial has found.
Results from the Serena-6 trial, carried out with the Institute of Cancer Research in London, suggest that using camizestrant could help patients stay well longer and delay the need for chemotherapy.
According to Cancer Research UK, the drug works by blocking oestrogen from getting into the breast cancer cell, which researchers hope can then stop or slow the growth of cancer.
Breast cancer patients given the drug in the trial reduced their chances of the disease progressing by 52% compared to standard therapies.
Professor Kristian Helin, chief executive of the Institute of Cancer Research, said the results "represent more than a clinical milestone, they represent a transformational shift in how we approach precision medicine".
Co-principal investigator Professor Nick Turner also called the development of the drug "a pivotal moment in breast cancer care".
1:48
The study, funded by AstraZeneca, looked at patients with hormone-positive, HER2-negative breast cancer - about 70% of cases.
More than 3,000 patients from 23 countries took part in phase three of the trial, which saw doctors use blood tests to detect changes in the cancer's DNA to see which treatments were ineffective.
For those taking camizestrant, their cancer stabilised for around 16 months on average, compared with about nine months for other treatments.
However, 1% of patients taking the new drug stopped taking it because of side effects.
Further results from the Serena-6 trial will be presented at the American Society of Clinical Oncology annual meeting in Chicago on Sunday.
Cancer Research UK reports that breast cancer is the most common type of the disease, with around 56,400 women and around 390 men diagnosed in the UK each year.
The trial was also the first worldwide study to show that using blood tests to find early signs of cancer resistance to treatment helps patients.
Dr Catherine Elliott, director of research at Cancer Research UK, praised the breakthrough as a "clear example of how blood tests are starting to transform cancer treatment".
"By tracking tiny traces of tumour DNA in the blood, researchers were able to spot early signs of treatment resistance and switch therapies before cancer had a chance to grow," she added.
"It shows how circulating tumour DNA, or ctDNA, could help doctors make smarter, more timely treatment decisions.
"This approach could become an important part of how we personalise care for people with advanced breast cancer."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Western Telegraph
28 minutes ago
- Western Telegraph
Buy now pay later provider Zilch to launch first physical card
The fintech, which has been named one of the fastest-growing in the UK, said it means more of its customers can make payments in stores. Zilch currently offers a virtual card, stored in its app or in people's mobile wallets, which links to customers' debit cards and means they can pay for shopping flexibly. Buy now, pay later providers like Klarna and Clearpay have come under new standards since legislation was introduced last month (Tim Goode/PA) People can choose to pay in full, or spread payments over six weeks or three months, at retailers from Primark and Asos to Just Eat and eBay. While the virtual card can be used in shops as well as online, Zilch said that nearly 80% of UK adults do not regularly use mobile wallets so having a physical card will drive more transactions. It is also set to open up buy-now-pay-later options for bigger purchases like home repairs, hotel check-ins, and car rentals. The cards will become available to its existing customers from September. The London-based company has grown its customer base to more than five million since launching five year ago and securing authorisation from the UK's Financial Conduct Authority. It reached a valuation of two billion dollars (£1.5 billion) in 2021 and was named one of the UK's fastest-growing fintech unicorns this year. Buy now, pay later providers like Klarna and Clearpay have come under new standards since legislation was introduced last month. It came amid concerns that a lack of regulation has led some of the 10 million people who use it to take on too much debt.
Daily Mail
33 minutes ago
- Daily Mail
Florian Wirtz transfer latest: Liverpool still £10m short of Bayer Leverkusen's asking price for Germany star as Bundesliga club hold out for British-record fee
Liverpool remain in negotiations with Bayer Leverkusen over a deal for Florian Wirtz. Bayer want £120million and Liverpool are at £109m but Wirtz has made it clear he wants the move. The Germany star has been convinced by Arne Slot 's clear plan of where he will play in Liverpool's set-up as a No 10. Should the Reds accede to Bayer's demands, Wirtz would become the most expensive signing in British football, overtaking the £115m Chelsea paid Brighton for Moises Caicedo. Richard Hughes, Liverpool's Sporting Director, has proposed a package to his Leverkusen counterpart Simon Rolfes with easily attainable performance-related bonuses, such as Champions League qualification but the clubs are yet to agree a final fee. Talks will continue on Tuesday as the club attempt to find a middle ground. There is also a possibility that Bayer could bring a Liverpool player to Germany as part of the deal. Harvey Elliott and Jarell Quansah are both admired by Leverkusen, and either could be proposed as makeweight. Liverpool have already successfully conducted business with Bayer this summer, signing Jeremie Frimpong for £29.5m last week. Further talks are expected to take place this week with Bournemouth also for £40m-rated left-back Milos Kerkez. Hughes was Bournemouth's technical director at the time the south coast club snapped up the Hungary international from Dutch side AZ two years ago. Liverpool have yet to receive an approach from Everton for Ben Doak despite the winger being of interest to manager David Moyes. The former Celtic youth, who has been capped six times by Scotland at senior international level, spent the 2024-25 season out on loan at Middlesbrough. Doak impressed at the Riverside, producing seven assists and three goals in 24 Championship appearances.
Daily Mail
33 minutes ago
- Daily Mail
Viktor Gyokeres has an incredible goal record and is a ready-made star, but Benjamin Sesko is proven in a major European league and has huge potential... so who should Arsenal sign this summer?
In an ideal world for Arsenal, Aston Villa would have beaten Man United on the final day of the season to edge Newcastle out of the picture in the race for the Champions League. There is no particular malice behind that thought, although a demoralising Carabao Cup semi-final defeat by the Magpies means Eddie Howe 's side aren't viewed particularly fondly by Gunners fans. But rather Toon striker Alexander Isak was viewed as a dream summer target for Mikel Arteta as he looks to reinforce his attacking options, yet given Champions League football will be returning to St James' Park, any move can now be ruled out. Nevertheless, it is still expected to be a big few months for Arsenal, boosted by a strong PSR position - and purse strings will be loosened as they try to strengthen across a variety of positions. There is no doubt that No 9 is the biggest priority though, with the lack of a quality option playing a big part in the third successive second place finish for Arteta's side as they drew 14 of their 38 Premier League games to finish 10 points adrift of Liverpool. Sporting Lisbon's Viktor Gyokeres and RB Leipzig's Benjamin Sesko are the two main contenders, but Arsenal fans and those inside the club are torn on who would be the better option. Both Gyokeres and Sesko are top class strikers in their own right and each have plenty of positives - and impressive goal records - to boost their case to Arsenal's recruitment team. On the one hand, a move for Sesko would make sense given the Slovenian star has been a long-term target. The Gunners have previously done much of the groundwork on a potential deal, having been close to signing him last summer before the player became unsure over how much game time he would get. Sesko has since netted 26 goals for club and country this season and at 21, the striker, who turns 22 on Saturday, presents an ideal profile for future growth. A transfer to Arsenal also feels like the perfect next step for Sesko, who has carefully constructed his career to date. After moving to Red Bull Salzburg at 16, he initially impressed on loan at their sister club FC Liefering who play in the Austrian second tier. Two strong seasons saw him score 22 goals in 44 games when he then made the step up to Salzburg's first team to fill the void left by Erling Haaland's departure to Borussia Dortmund in 2020. Sesko thrived and in the summer of 2023 he had interest from several teams across Europe, before he ultimately chose to join RB Leipzig to stay within the Red Bull network. Sesko almost joined Arsenal last summer and the Gunners have done due diligence on him In Germany, Sesko has gained crucial experience in a major European league and performed well despite Leipzig enduring two difficult campaigns. In 2024-25 he netted 21 times in 45 games, even though Leipzig crashed out in the League Phase of the Champions League following seven defeats in eight games and finished seventh in the Bundesliga. Sesko's variety of goals are also an added positive for potential suitors, with the 21-year-old having netted just six times from the penalty spot this season. Sesko is strong with both feet and has scored multiple headers - and overall he has an impressive career record of 90 goals and 25 assists in 210 matches. His experience of the Champions League would also be useful to Arsenal, although he is yet to enjoy any real success in the competition. Across four seasons, Sesko has scored just six goals in 28 games. However, it must be noted that the 21-year-old has generally played for teams that have struggled in the Champions League and he did manage to net four times in eight matches this time around. But when Arsenal are weighing up whether or not to go for Sesko, who is valued at £92.5m, there are also several factors that may encourage them to go for Gyokeres. The Swedish forward has enjoyed an incredible two years at Sporting and he is widely expected to leave Portugal this summer. In fact, it is understood that Sporting are currently searching for a new striker to replace the former Brighton and Coventry frontman. The Portuguese side are demanding in excess of £70m, meaning the Swede's options are limited to a few clubs with the financial power and willingness to spend that on a player. But Arsenal are one such team, and new sporting director Andrea Berta is said to admire Gyokeres from his time working at Atletico Madrid. And you can see why, with Gyokeres possessing an superb record of 97 goals in 102 games since joining Sporting for a bargain £20.2m fee. A 2024-25 campaign that saw the Swede net 54 goals and add 13 assists in 52 games has meant Gyokeres' profile has risen exponentially, something that was particularly boosted by his Champions League form. On what was his first experience of the competition, Gyokeres scored six goals in eight games, included a superb hat-trick against Man City in November. His rise has been less serene than Sesko's, with the 26-year-old, whose birthday is next week, failing to make the grade at Brighton during a four-year spell that also saw him struggle on loan at Swansea. However, a flame was lit once he joined Coventry and 40 goals across two seasons as a permanent player earned Gyokeres a move to Sporting. Despite his incredible record, there are a few concerns surrounding Gyokeres, including the fact that he will be 27 at the start of next season, five years senior to Sesko. His struggles at Brighton, although they now seem irrelevant, do raise some questions given he has never played in a top five European league, something Sesko has done with the Bundesliga. Mail Sport has previously reported how this is a view echoed internally at Arsenal, with figures torn on whether the striker can hit the ground running in the Premier League. There is also the fact that 20 of his 54 goals this season were penalties, although given Gyokeres scored every spot kick, perhaps that is something to be viewed positively. He also struggled to assert himself during Sporting's 5-1 thrashing by Arsenal in the Champions League. Nevertheless, the Swede's international record is impressive, with Gyokeres having netted 15 times in 26 games in comparison to Sesko's 16 in 41 for Slovenia, although again the standard of their respective teams should be taken into account. Whatever they decide, it feels as if Arsenal will be getting a top quality striker this summer and one that they hope will take them to a trophy after more than five years. Both strikers have their qualities, with Gyokeres possessing an incredible goal record over the past two years. In fact, in 2024-25, the 26-year-old averaged a goal every 79 minutes and converted 56 per cent of his chances. This outperformed Sesko, whose goal-per-minute ratio is 156, while he has a conversation rate of 47.1 per cent. A caveat to that is the quality of their leagues and the fact Gyokeres had 3.9 shots per game compared to Sesko's 2.31. He also averaged 9.16 touches in the opposition box, almost three times that of the Slovenian's 3.29. Overall, it feels like although Sesko has a poorer goal record than his striking rival, the fact that he is proven in a major European league and on an upward curve is extremely appealing. Arsenal have also done plenty of due diligence on him as a target and they have been tracking the 21-year-old for a long-time. The Gunners have plenty of money to spend this summer and although Sesko is likely to be more expensive than Gyokeres, his physicality, age and potential mean Mail Sport favours him narrowly as the better option.
